LCM
SGMT icon

Landscape Capital Management’s Sagimet Biosciences SGMT Stock Holding History

Landscape Capital Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174K Buy
33,391
+7,490
+29% +$41.7K 0.01% 645
2025
Q4 		$153K Buy
25,901
+3,198
+14% +$23K 0.01% 635
2025
Q3 		$156K Buy
+22,703
New +$184K 0.01% 567

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Landscape Capital Management's SGMT Position: Q1 2026 in Review

Landscape Capital Management increased its Sagimet Biosciences (SGMT) stake by 29% in Q1 2026, buying an estimated $41.7K and bringing the position to 33,391 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #645.

Landscape Capital Management first reported a position in SGMT in Q3 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Landscape Capital Management held 33,391 shares of Sagimet Biosciences worth $174K as of Q1 2026.
  • Landscape Capital Management bought 7,490 Sagimet Biosciences shares in Q1 2026, an estimated $41.7K.
  • Sagimet Biosciences made up 0.01% of Landscape Capital Management's portfolio in Q1 2026, its #645 holding.
  • Landscape Capital Management first reported a position in Sagimet Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.